vinflunine,docetaxel,erdafitinib,pembrolizumab
pierre fabre,merck,janssen
['bladder', 'thor trial', '#thor', 'erdafitinib', 'congrat']
phase 3 #thor trial reading out means erdafitinib is the right life extending option for patients with #fgfr alterations in #bladdercancer congratulations and the #thor team!! #asco23 
I treat & research GU cancers @UTSW Dallas. Columbia/Harvard Med/Duke alum; Mom & wife Tweets=my opinions ASCO: https://t.co/Whk29PATXe